Reducing sugar, fat, and salt for prevention and control of noncommunicable diseases (NCDs) as an adopted health policy in Iran (original) (raw)

Abstract

Background: Tackling noncommunicable diseases (NCDs) and their multifaceted, complex risk factors requires identifying policy gaps and translation of successful experiences for each setting. As advocated by World Health Organization (WHO), reducing sugar, salt, and fat are among best buys for prevention and control of NCDs. This article reports the status of existing policies to reduce the consumption of sugar, salt, and fat in Iran. Methods: We created a comprehensive repository of available policy documents about sugar, salt, and fat policies in Iran and conducted content analysis and interviews with relevant stakeholders. Then, we compared policies and their content with the WHO's best buys' recommendations. Results: We categorized policies in 3 groups: red colour (no mention in the policy documents), amber (inspirational policy mention without action), and green (policy in operation). For example, regarding sugar, we found 8 policies in green, 1 in amber. Our matrix of policies on all 3 topics created a platform for further policy analysis and transferrable lessons to improve national actions towards 30% reduction of death due to NCDs in Iran. Conclusion: It has been globally recognized that beyond technical solutions to combat NCDs, feasible and meaningful policy solutions must be created that are aligned with the political economy of each context. This necessitates learning from national, regional, and global experiences to manage the political economy of NCDs' main determinants. To this end, our study provides a systematic and evidencebased framework, which may also be beneficial for other nations.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (26)

  1. Bakhtiari A, Takian A. Majdzadeh R, Haghdoost Aa. Assessment and prioritization of the WHO "best buys" and other recommended inter- ventions for the prevention and control of non-communicable diseases in Iran. BMC Public Health. 2020;20(1):1-6.
  2. Noncommunicable diseases country profiles 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
  3. Mokdad AH, Forouzanfar MH, Daoud F, El Bcheraoui C, Moradi- Lakeh M, Khalil I, et al. Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob Health. 2016;4(10):e704- e13.
  4. Renshaw N, Dissard R, Beagley J. A breath of fresh air acting on the UN mandate to tackle air pollution. NCD Alliance. October 2018.
  5. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and riskfactor clusters in 21 regions, 1990e2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2224e60.
  6. 2013-2020 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva, Switzerland: World Health Organization; 2013.
  7. Roberts NL, Mountjoy-Venning WC, Anjomshoa M, Banoub JAM, Yasin YJ. GBD 2017 Disease and Injury Incidence and Prevalence Col- laborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study (vol 392, pg 1789, 2018). Lancet. 2019;393(10190):E44-E.
  8. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151-210.
  9. Institute for Health Metrics and Evaluation, University of Washington (2018), Global burden of diseases 2016. https://vizhub.healthdata. org/gbd-compare/
  10. David J, Hunter KSR. Noncommunicable diseases. N Engl J Med. 2013; 369:1336-43.
  11. Peykari N, Djalalinia S, Qorbani M, Sobhani S, Farzadfar F, Larijani B. Socioeconomic inequalities and diabetes: a systematic review from Iran. J Diabetes Metab Disord. 2015;14:8.
  12. Report on the Consultation on developing strategic directions for salt and fat reduction in the Eastern Mediterranean Region. WHO- EM/NUT/260/E.
  13. Swinburn B, Sacks G, Vandevijvere S, Kumanyika S, Lobstein T, Neal B, et al. INFORMAS (I nternational N etwork for F ood and O besity/non-communicable diseases R esearch, M onitoring and A ction S upport): overview and key principles. Obes rev. 2013;14:1-12.
  14. Hawkes C. Food policies for healthy populations and healthy econo- mies. BMJ. 2012;344:e2801.
  15. Gilson L, Raphaely N. The terrain of health policy analysis in low and middle income countries: a review of the literature 1994-2005. Paper presented to a Workshop on Health Policy Analysis, London, 21-22 May 2007.
  16. Tashakkori A, Teddlie C. Handbook of mixed methods in Social & Behavioral Research. SAGE Ltd. 2013:297-320.
  17. Mogalakwe M. The use of documentary research methods in social research. Afr Soc Rev. 2016;10(1):221-230.
  18. World Health Organization. Islamic Republic of Iran on a Fast-Track to Beating Noncommunicable Diseases; 2017. Available from: http:// www.who.int/features/2017/iran-noncommunicable-diseases/en/.
  19. Noncommunicable Diseases Progress Monitor 2015. Geneva: World Downloaded from mjiri.iums.ac.ir at 14:21 IRST on Tuesday December 14th 2021 [ DOI: 10.47176/mjiri.34.136 ] Policy analysis against NCDs in Iran http://mjiri.iums.ac.ir Med J Islam Repub Iran. 2020 (13 Oct); 34:136.
  20. Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable dis- eases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3.
  21. Report on the Technical consultation on salt and fat reduction strate- gies in the Eastern Mediterranean Region. Tunis, Tunisia. 30-31 March 2015
  22. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a sys- tematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3(12).
  23. Food and Drug Administration (FDA) of Iran, 2018. Available from: http://fda.gov.ir/service
  24. Rezaeia Sh, Mahmoudia Z, Sheidaeia A, Aryana Z, Mahmoudia N, Gohari K. et al. Salt intake among Iranian population: the first national report on salt intake in Iran. J Hypertens. 2018;36.
  25. Peymani P, Joulaie H, Zamiri N, Ahmadi SM, Dinarvand R, Hosseini H, et al. Iran's experience on reduction of trans-fatty acid content in ed- ible oils. Middle-East J Sci Re. 2012;11(9):1207-11.
  26. Downloaded from mjiri.iums.ac.ir at 14:21 IRST on Tuesday December 14th 2021 [ DOI: 10.47176/mjiri.34.136 ]